PureTech Health plc (OTCMKTS:PTCHF – Get Free Report)’s share price traded up 12.1% during mid-day trading on Tuesday . The company traded as high as $1.7483 and last traded at $1.7483. 464,871 shares traded hands during trading, an increase of 706% from the average session volume of 57,643 shares. The stock had previously closed at $1.56.
PureTech Health Stock Performance
The business’s 50 day simple moving average is $1.64 and its 200-day simple moving average is $1.68.
PureTech Health Company Profile
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Read More
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
